This opportunity is no longer accepting applications.
grant PAR-21-124

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

This grant opportunity supports research projects focused on developing laboratory tests to identify and study potential treatments for neurological or neuromuscular disorders. The goal is to advance these projects to qualify for further development through initiatives like the Blueprint Neurotherapeutics Network.

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite …

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: March 11, 2021
Submission Deadline: October 21, 2024
Application Window Closes: October 21, 2024
Open for Submission: March 11, 2021

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.